BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mipletamig readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Mipletamig\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06634394-2852@assetmemo.bio
DTSTAMP:20261121T005430Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:Mipletamig: Phase 1 readout est. (NCT06634394)
DESCRIPTION:Mipletamig\, phase 1\, Acute Myeloid Leukemia.\nStudy: APVO436 
 Phase 1b/2 Study in Patients With Newly Diagnosed AML\nEstimated primary c
 ompletion: October 2027. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/mipletamig#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT06634394
URL:https://assetmemo.bio/drug/mipletamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
